I will start with some full-year highlights, discuss our fourth quarter performance, and touch briefly on our expectations for fiscal 2026. We ended the year on a high note, and I will provide some details on the fourth quarter, including by segment. In Mobile Solutions, our strength in aftermarket is contributing to record results as we continue to win and gain share in our independent channel, which eclipsed $1 billion in sales this year. Create in dust collection we are building new customer relationships and our OE channel sales hit record levels.
Through this we are strengthening our customer relationships and building this revenue stream for the future. Replace our razor-to-sell razor blade aftermarket model is working with almost 50% of our quarterly industrial segment sales now driven by higher margin aftermarket sales service. This quarter we acquired our third service business, RPS Associates of New England. Moving to life sciences, food and beverage sales grew over 20% both in new and replacement parts sales.
We are winning share through key OEMs and channel partners in this high margin business. Overall sales increased 5% year-over-year to $981 million, driven by volume growth, currency translation benefits, and pricing. On-time delivery rates remain high, and our backlogs support our outlook over multiple quarters. Aftermarket sales were $468 million, up 3%, driven by strong demand in the OE channel from larger customers and market share gains in the independent channel.
| Metric | Period | Current guidance |
|---|---|---|
| Total sales growth | FY2026 | 1% to 5% (~$3.8B at midpoint, ~1% pricing) (new) |
| Operating margin | FY2026 | 16.1% to 16.7%, ~70 bps YoY improvement (new) |
| EPS | FY2026 | $3.92 to $4.08 (centered on $4.00) (new) |
| Incremental margin | FY2026 | approximately 40% (new) |
| Cash conversion | FY2026 | 85% to 95% (new) |
| Mobile Solutions sales | FY2026 | flat to up 4% (new) |
| Industrial Solutions sales | FY2026 | 2% to 6% growth (new) |
| Life Sciences sales | FY2026 | 1% to 5% growth (new) |
| Metric | YoY | Note |
|---|---|---|
| Total sales | +5% to $981M | Volume growth, currency translation benefits, and pricing |
| Adjusted EPS | +~10% to $1.03 | Higher sales and operating margin expansion |
| Operating margin | +10 bps to record 16.4% | Operating expense leverage offsetting gross margin decline |
| Gross margin | -140 bps to 34.8% | Tariff-related inflation on LIFO inventory valuation accounted for nearly all the change |
| Mobile Solutions sales | +2% to $588M | Aftermarket up 3% on OE channel demand and independent channel share gains |
| Industrial Solutions sales | +8% to $310M | Double-digit IFS growth, dust collection and power generation strength |
| Mobile Solutions pre-tax margin | +80 bps to record 19.1% | Timing of inventory adjustments and leverage on higher sales |
| Industrial Solutions pre-tax margin | +80 bps to record 20.9% | Leverage on higher sales |
| Life Sciences pre-tax margin | +6.5 pts to 5.3% (from -1.2%) | Food and beverage and disk drive strength plus optimized cost structure |
| Topic | Previous mention | Current period | Trend |
|---|---|---|---|
| Tariffs | Significant LIFO inflation impact in Q4 | Company plans to be profit neutral over time on ongoing tariffs | Managing |
| Footprint and cost optimization | Heavy lift phase ongoing | Expected to be mostly complete by second half of fiscal 2026 | Progressing |
| Power Gen super cycle | Strong | Business is full, no end in sight, longest backlog look in the company | Improving |
| Agriculture / off-road end market | Eight consecutive quarters of declines | Bottomed within the quarter with slight low-single-digit uptick | Improving |
| Bioprocessing commercialization | Delayed relative to earlier expectations | Meaningful revenue inflection more likely in fiscal 2027 | Stable |
| Razor-to-razor-blade aftermarket model | Growing replacement part mix | Almost 50% of industrial segment sales now replacement parts (up from 35%-40% historically) | Improving |